PUMA SE (PUM)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 24.81 |
|---|---|
| 52-week range | 15.30 – 30.31 |
| Return, 1 month / 3 months | +11.0% / −12.9% |
| Return, 1 year / 3 years | +13.5% / −51.1% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 50.8% |
| Worst drawdown (1 year) | -27.7% |
| Average daily value traded | 13.27M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Puma is a German sportswear company based in Herzogenaurach that designs and sells athletic footwear, apparel and accessories. Its products include running and training shoes, football boots, lifestyle sneakers, sportswear and golf equipment, sold under the Puma brand and its golf label. The company serves retail customers and athletes across the world through sports retailers, its own stores and online channels, and it also supplies kits and gear to football clubs and national teams.
The shares are listed on the Deutsche Börse Xetra in Germany under the code PUM, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
PUMA SE (PUM) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 24.81 on 27 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 364 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.5% and over the last three months it fell 12.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 0.2% | ||
| From 52-week high | -17.3% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.9% | ||
| 6-month return | -1.1% | ||
| 12-month return, skipping the last month | 2.3% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 50.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.7% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 13.27M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | +11.0% |
| 3 months | −12.9% |
| 6 months | −1.1% |
| 1 year | +13.5% |
| 3 years | −51.1% |
| 5 years | −74.9% |
Signals
| 50-day / 200-day average | 23.58 / 24.77 |
|---|---|
| Golden / death cross (60 days) | Death, 16 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.78 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 May 2025 | EUR 0.6100 |
| 23 May 2024 | EUR 0.8200 |
| 25 May 2023 | EUR 0.8200 |
| 12 May 2022 | EUR 0.7200 |
| 6 May 2021 | EUR 0.1600 |
| 8 May 2020 | EUR 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.